Your AI Doctor Is Coming | Julie Yoo
a16z PodcastFull Title
Your AI Doctor Is Coming | Julie Yoo
Summary
This episode discusses how AI is poised to revolutionize the healthcare industry, which has historically been slow to adopt technology.
Key factors enabling this transformation include shifts in consumer expectations, cost pressures on incumbents, and the emergence of AI-native solutions that can leapfrog legacy systems.
Key Points
- Julie Yoo, an a16z partner with extensive experience in health tech, believes healthcare is uniquely positioned to benefit most from AI due to its high costs and scarcity of expertise.
- Healthcare's slow adoption of technology, characterized by paper records and manual processes, was partially addressed by government incentives for electronic health records, but this was a foundational step rather than a true technological leap.
- The COVID-19 pandemic acted as a catalyst, forcing the relaxation of regulations around telehealth and demonstrating the need for digital modalities in healthcare access.
- AI's advancement, particularly with large language models (LLMs), offers the potential to overcome the inherent complexities and expertise requirements in healthcare, which were previously significant barriers to technological integration.
- The healthcare industry is now experiencing an "organic adoption wave" of AI, driven by the clear utility of tools like AI scribes, unlike previous tech adoptions that required financial incentives or crises.
- Consumers are increasingly expecting the same level of digital convenience in healthcare as they experience in other sectors (e.g., Uber, Airbnb), leading to a demand for better, more accessible services.
- The traditional healthcare system faces significant cost pressures due to rising labor expenses, a post-COVID exodus of talent, and government-imposed cost controls, creating an imperative for change.
- The existing third-party payer system in healthcare contributes to bloat as consumers do not directly feel the financial pain of expenses, but this is shifting with increased deductibles and cost-sharing.
- AI enables a "leapfrog dynamic" in healthcare technology, allowing the industry to move directly to AI-native workflows without the need to rip and replace decades of legacy software and infrastructure as seen in other industries.
- Opportunities for founders exist in consumer healthcare, AI-native care delivery, robotics, and innovative payment models, focusing on AI-native and AI-proof solutions.
- The future will likely involve highly personalized, "end-of-one" healthcare solutions powered by AI, with an "AI doctor in your pocket for life" that possesses deep knowledge of an individual's health history.
- The development of robust AI models in healthcare is dependent on generating new, longitudinal datasets from "N1 experiments," as current EHR data is often sporadic and incomplete.
Conclusion
AI is rapidly transforming the healthcare industry, moving beyond initial digitization to enable AI-native workflows and personalized patient experiences.
The convergence of increased consumer expectations, cost pressures, and AI advancements has created a fertile ground for innovation in health tech.
The future of healthcare will be characterized by highly personalized, accessible, and continuously available care, with AI playing a central role in delivering these services.
Discussion Topics
- How will the integration of AI doctors impact the patient-physician relationship?
- What are the biggest ethical considerations we need to address as AI becomes more prevalent in healthcare?
- Beyond diagnostics and administrative tasks, how else can AI fundamentally change the delivery and experience of healthcare for underserved populations?
Key Terms
- LLMs
- Large Language Models, a type of artificial intelligence capable of understanding and generating human-like text.
- EHRs
- Electronic Health Records, digital versions of patient health information.
- SaaS
- Software as a Service, a software distribution model where a third-party provider hosts applications and makes them available to customers over the Internet.
- ERP
- Enterprise Resource Planning, systems that integrate various business processes into a single system.
- PLG
- Product-Led Growth, a business strategy that relies on the product itself to drive customer acquisition, retention, and expansion.
- N1 experiments
- Experiments or solutions tailored to a single individual, often generating unique data.
Timeline
Julie Yu believes AI could address the high costs and scarcity of time and medical expertise in healthcare.
Yoo shares her personal journey into healthcare, noting she was "too early" with technology adoption in the industry.
The federal government incentivized the digitization of healthcare through electronic health records, marking a transition into the modern era.
Yoo's initial focus was in the genomics era, an early area of explosive data growth in healthcare.
The founding thesis of Kairos, Yoo's company, was to solve the patient access paradox by optimizing appointment inventory and physician utilization.
In the past, healthcare was seen as a difficult industry for venture capital due to regulation, slow pace, and high stakes.
Yoo's company achieved a successful exit, highlighting a decade of effort leading to a significant outcome.
The last seven years have seen remarkable acceleration in health tech, driven by COVID-19 and AI.
COVID-19 forced a digital modality for healthcare engagement and revealed previously held assumptions about system constraints, such as state-level physician licensing.
Relaxation of payment rules for telehealth during the pandemic provided crucial tailwinds for digital health companies.
Yoo believes healthcare will benefit the most from AI due to accelerated growth and adoption seen in recent years.
A healthcare industry renaissance has occurred due to a confidence factor, increasing consumer expectations, and cost pressures on incumbents.
Consumers are reaching a breaking point with stagnant healthcare experiences compared to other service industries, leading them to seek better alternatives.
The incumbent healthcare industry is under pressure from increased costs, labor shortages, and government regulation, making their current business models unsustainable.
The third-party payer system in healthcare contributes to bloat because consumers do not directly experience the financial pain of spending.
AI, particularly LLMs, is now capable of replicating expertise that was previously difficult to achieve through technology, overcoming the historically scarce and training-oriented nature of healthcare professions.
AI's benefits in healthcare span disease discovery, drug development, and consumer-facing applications, with the potential to improve accessibility and efficiency across the entire stack.
Healthcare's historical low investment in technology has created an opportunity for a "leapfrog dynamic," allowing direct adoption of AI-native workflows.
AI has facilitated the first truly organic adoption wave in health tech, with doctors using AI scribes because they are effective and improve their jobs.
On the consumer side, LLMs are being used for health-related questions, becoming more accurate and integrated into marketplaces for booking appointments.
New companies are leveraging AI to create consumer-grade experiences, offering AI-native doctor practices with 24/7 chat modalities involving licensed MDs.
A hackathon focused on rare diseases demonstrated AI's potential to analyze genomic and clinical data for insights, saving lives.
The major opportunities in health tech lie in lowering the barrier to intelligence, providing verification and clinical-grade testing, and developing longitudinal care solutions.
The best opportunities are in consumer healthcare, AI-native and AI-proof companies, robotics, and new insurance payment models.
Consumer healthcare is a significant opportunity, with companies now able to offer cash-pay services at disruptively low prices due to AI's reduced cost structure.
AI-native and AI-proof companies are crucial, integrating AI into their core operations to deliver services not achievable through historical means or at a disruptive cost structure.
Robotics companies are finding market fit in high-acuity healthcare settings.
Ambitious companies are working to redesign the current healthcare payment modality and build new systems from scratch.
In a decade, personalized "end-of-one" healthcare solutions will be common, with individuals having an AI doctor in their pocket that knows them intimately.
Generating new data rails through N1 experiments is essential for training the next generation of medical-grade AI models.
Episode Details
- Podcast
- a16z Podcast
- Episode
- Your AI Doctor Is Coming | Julie Yoo
- Official Link
- https://a16z.com/podcasts/a16z-podcast/
- Published
- September 6, 2026